| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.008 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.009 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.15 | 0.009 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.009 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.082 | 0.01 |